Hisao Shirohzu

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignee: Bonac Corporation. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hisao Shirohzu. Retrieved from https://idiyas.com/inventor/hisao-shirohzu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 66.7

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 20(Granted Patents)

Location History:

Fukuoka, JP (2015)
Kurume, JP (2014 - 2019)

Company Filing History:

6 out of 19

Bonac Corporation

patents

Years Active: 2014-2019

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10233446 - Micro-RNA inhibitor (2019-03-19),

2. 9404108 - Micro-RMA inhibitor (2016-08-02),

3. 9206422 - Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton (2015-12-08),

4. 9200278 - Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton (2015-12-01),

5. 8785121 - Single-stranded nucleic acid molecule for controlling gene expression (2014-07-22),

6. 8691782 - Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton (2014-04-08),

Title: Hisao Shirohzu: Innovator in MicroRNA Inhibition

Introduction

Hisao Shirohzu is a prominent inventor based in Kurume, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of microRNA inhibitors. With a total of 6 patents to his name, Shirohzu's work has the potential to impact various medical applications.

Latest Patents

His latest patents include innovative inventions related to microRNA inhibitors. The first invention provides a microRNA inhibitor that has two or more sequences complementary to the target microRNA sequence. These complementary sequences are linked via one or more linker residues. The second invention, similarly, offers a microRNA inhibitor with the same structural characteristics, enhancing the potential for targeted inhibition of microRNA.

Career Highlights

Shirohzu is currently associated with Bonac Corporation, where he continues to advance his research and development efforts. His work at Bonac Corporation has positioned him as a key player in the biotechnology sector, focusing on innovative solutions for complex biological challenges.

Collaborations

Some of his notable coworkers include Tadaaki Ohgi and Tomohiro Hamasaki. Their collaborative efforts contribute to the innovative environment at Bonac Corporation, fostering advancements in biotechnology.

Conclusion

Hisao Shirohzu's contributions to the field of microRNA inhibitors exemplify the importance of innovation in biotechnology. His work not only showcases his expertise but also highlights the collaborative spirit within his organization.

Profile summary based on public USPTO records.